ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 113

$524K Total Retail Price of All Prescriptions

Rank: 28 out of 113

436 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 436 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,406 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 430 399 1 1
AMLODIPINE BESYLATE 325 304 2 4
SIMVASTATIN 324 300 3 2
FUROSEMIDE 300 299 4 6
ATORVASTATIN CALCIUM 260 248 5 15
POTASSIUM CHLORIDE 213 200 6 12
ZOLPIDEM TARTRATE 212 197 7 19
WARFARIN SODIUM 208 197 8 8
LOSARTAN POTASSIUM 203 202 9 13
METFORMIN HCL 201 136 10 11
HYDROCHLOROTHIAZIDE 176 170 11 9
LISINOPRIL 166 138 12 3
TRIAMTERENE-HCTZ 157 144 13 26
TRAZODONE HCL 146 115 14 41
LOSARTAN-HYDROCHLOROTHIAZIDE 144 132 15 40
METOPROLOL SUCCINATE 139 130 16 10
CRESTOR 129 127 17 30
OMEPRAZOLE 122 102 18 5
CITALOPRAM HBR 112 97 19 17
GABAPENTIN 112 73 19 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 75 21 34
ALLOPURINOL 101 97 22 20
ATENOLOL 100 85 23 16
LANTUS 86 59 24 38
ESCITALOPRAM OXALATE 85 64 25 86
HYDROCODONE-ACETAMINOPHEN 85 72 S3 25 7
TAMSULOSIN HCL 84 77 27 24
OXYCODONE HCL 82 68 S2 28 62
SERTRALINE HCL 76 53 29 21
TRAMADOL HCL 69 45 30 29
ALFUZOSIN HCL 65 61 31 183
PANTOPRAZOLE SODIUM 64 54 32 52
PREDNISONE 63 56 33 28
LYRICA 59 47 34 83
CELEBREX 57 55 35 90
MORPHINE SULFATE ER 55 36 S2 36 79
CARVEDILOL 52 52 37 25
FLUTICASONE PROPIONATE 52 52 37 39
NABUMETONE 51 30 39 201
BENAZEPRIL HCL 51 51 39 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.